Osteoarthritis
Conditions
Interventions
Experimental group I: 10 elderly men and women performed muscle strengthening exercises of the hip, knee and ankle joints at 70% of a maximal repetition, using weight shiners, for 4 weeks, 3 times a w
Other
E02.760.169.063.500.387
Sponsors
Universidade São Judas Tadeu
Universidade de São Paulo
Eligibility
Age
50 Years to 100 Years
Inclusion criteria
Inclusion criteria: Healthy volunteers; both genders; age between 50 and 90 years; present a medical report or radiographic evidence of OA according to the Kellgren and Lawrence scale; knee pain over the last week, be physically independent.
Exclusion criteria
Exclusion criteria: To present pathologies in incapacitating levels; having a diagnosis of fibromyalgia or rheumatoid arthritis; use of corticosteroid or intra-articular hyaluronic acid in the last 12 months; oral use of anti-inflammatory drugs last 2 months; participation in a neuromuscular strengthening or exercise program or other (non-pharmacological) treatment for knee OA in the last six months; prosthesis or any other surgery on the hip and knee joints; decompensated heart diseases; hearing or visual impairment. Participants were asked to refrain from seeking other forms of treatment during the exercise protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Significant regression (p <= 0.05) of pain levels using Visual Analogue Scale parameters (0-100 mm) after treatment termination.;Outcome 1: Significant regression (p = 0.001) of 35mm of pain levels by Visual Analogue Scale (0-100mm) after treatment termination.;Expected outcome 2: Significant regression (p <= 0.05) Western Ontario McMaster Universities scale after treatment termination.;Outcome found 2: Significant regression (p <= 0.005) 3.5 points of scale of Western Ontario McMaster Universities after termination of treatment.;Expected outcome 3: Significant regression (p <= 0.05) on the Mcgill Pain Questionnaire after treatment termination.;Outcome found 3: Significant regression (p <= 0.05) of 3.5 points on the Mcgill Pain Questionnaire after termination of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactFelipe Bersotti
Universidade São Judas Tadeu
Outcome results
None listed